Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis
Related Experiment Video
Updated: May 18, 2026

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans
Published on: February 27, 2018
Darin L Wiesner1, Oleksandr Moskalenko, Jennifer M Corcoran
1Department of Microbiology, Medical School, University of Minnesota, Minneapolis, Minnesota, USA.
Unlabelled:
In sub-Saharan Africa, cryptococcal meningitis (CM) continues to be a predominant cause of AIDS-related mortality. Understanding virulence and improving clinical treatments remain important. To characterize the role of the fungal strain genotype in clinical disease, we analyzed 140 Cryptococcus isolates from 111 Ugandans with AIDS and CM. Isolates consisted of 107 nonredundant Cryptococcus neoformans var. grubii strains and 8 C. neoformans var. grubii/neoformans hybrid strains. Multilocus sequence typing (MLST) was used to characterize genotypes, yielding 15 sequence types and 4 clonal clusters. The largest clonal cluster consisted of 74 isolates. The results of Burst and phylogenetic analysis suggested that the C. neoformans var. grubii strains could be separated into three nonredundant evolutionary groups (Burst group 1 to group 3). Patient mortality was differentially associated with the different evolutionary groups (P = 0.04), with the highest mortality observed among Burst group 1, Burst group 2, and hybrid strains. Compared to Burst group 3 strains, Burst group 1 strains were associated with higher mortality (P = 0.02), exhibited increased capsule shedding (P = 0.02), and elicited a more pronounced Th(2) response during ex vivo cytokine release assays with strain-specific capsule stimulation (P = 0.02). The results of these analyses suggest that cryptococcal strain variation can be an important determinant of human immune responses and mortality.
Importance:
Cryptococcus neoformans is a common life-threatening human fungal pathogen that is responsible for an estimated 1 million cases of meningitis in HIV-infected patients annually. Virulence factors that are important in human disease have been identified, yet the impacts of the fungal strain genotype on virulence and outcomes of human infection remain poorly understood. Using an analysis of strain variation based on in vitro assays and clinical data from Ugandans living with AIDS and cryptococcal infection, we report that strain genotype predicts the type of immune response and mortality risk. These studies suggest that knowledge of the strain genotype during human infections could be used to predict disease outcomes and lead to improved treatment approaches aimed at targeting the specific combination of pathogen virulence and host response.
Insights
Cryptococcal meningitis (CM) in AIDS patients is linked to fungal strain variations. Specific genotypes, like Burst group 1, are associated with higher mortality and distinct immune responses, suggesting genotype impacts disease outcomes.
Area of Science:
- Mycology
- Infectious Diseases
- Immunology
Background:
- Cryptococcal meningitis (CM) is a leading cause of death in individuals with AIDS, particularly in sub-Saharan Africa.
- While virulence factors are known, the influence of Cryptococcus neoformans strain genotype on disease progression and patient outcomes remains unclear.
Purpose of the Study:
- To investigate the association between Cryptococcus neoformans strain genotypes and clinical outcomes in Ugandan patients with AIDS and CM.
- To understand how fungal strain variation influences host immune responses and mortality risk.
Main Methods:
- Analysis of 140 Cryptococcus isolates from 111 Ugandan patients with AIDS and CM.
- Multilocus sequence typing (MLST) to characterize fungal genotypes.
- Phylogenetic and in vitro assays (e.g., capsule shedding, cytokine release) to assess strain-specific virulence and immune responses.
Main Results:
- Identified 15 sequence types and 4 clonal clusters among the isolates, with 107 Cryptococcus neoformans var. grubii and 8 hybrid strains.
- Patient mortality was significantly associated with different evolutionary groups (P = 0.04), with highest mortality in Burst group 1, Burst group 2, and hybrid strains.
- Burst group 1 strains showed higher mortality (P = 0.02), increased capsule shedding (P = 0.02), and a more pronounced Th2 immune response (P = 0.02) compared to Burst group 3.
Conclusions:
- Cryptococcal strain genotype is a significant determinant of human immune responses and mortality in CM.
- Understanding strain variation can help predict disease outcomes and guide the development of targeted treatment strategies.
- Genotypic information may lead to improved management of cryptococcal infections in HIV-infected individuals.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Fungal Phylum Microsporidia
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Cytomegalovirus Disease
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...

